The potential mechanisms underlying the role of SREBP1 in tumor progression include promoting tumor growth by increasing lipid synthesis through the activation of its target genes, as shown in prostate cancer, gastric cancer, and bladder cancer (Du et al., 2012; Miyachi et al., 2013; Singh et al., 2019). Here, SREBF1 is linked to urinary bladder carcinoma.